Skip to main content
Skip to primary sidebar
About Us
Topics
Adverse Events (non-infectious)
Blood Donation
Cell Therapy
Coagulation & Plasma Transfusion
Platelet Transfusion
Policy and Guidelines
Quality Control and Regulatory
RBC Transfusion
Serology/Genotyping
Special Transfusion Situations
Transfusion Transmitted Infections
Continuing Education
Archives
Podcasts
Question of the Day
Search
Subscribe to Email Alerts
Follow us on
Search
Subscribe to Email Alerts
Participate in our Reader Survey
June 19, 2019
Loading…
Recommended
Serosurveillance of SARS-CoV-2 from Blood Donations across the U.S.
RBC Alloimmunization is a Predictor of HLA Alloimmunization
Distinct Proteomic Profiles after Transfusion with Plasma vs. Whole Blood among Trauma Patients
Show Comments
Comments on this article are closed.
Get the latest news. Subscribe to our mailing list.
Sign Up
